The Bill and Melinda Gates Foundation has committed $150 million towards manufacturing 100 million doses of potential COVID-19 vaccines specifically for low- and middle-income countries. Gates‘ millions ensure the Serum Institute of India can produce enough volume once a vaccine acquires regulatory approval, and ultimately keep the cost of each dose below $3.